{
  "id": "5e2dae57fbd6abf43b000012",
  "type": "summary",
  "question": "How do the plasma concentrations of amantadine extended release and amantadine immediate release compare?",
  "ideal_answer": "When it is given at bedtime, it reaches plasma concentration approximately twice the level achieved by amantadine immediate release.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29564954",
    "http://www.ncbi.nlm.nih.gov/pubmed/29777529"
  ],
  "snippets": [
    {
      "text": "When it is given at bedtime, it reaches plasma concentration approximately twice the level achieved by amantadine immediate release.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29564954",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PK modeling suggested the recommended daily ADS-5102 dosage (274\u00a0mg qhs) resulted in 1.4- to 2.0-fold higher amantadine plasma concentrations during the day versus amantadine IR.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29777529",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}